Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Naito

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|August 12, 2011
Early prostate cancer--treat or watch?Keisuke Shigeta, Yoichi Naito, Toshimi Takano
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 13, 2023
Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumoursYoichi Naito, Toshirou Nishida, Toshihiko Doi
Lancet (London, England)|January 11, 2011
Cabazitaxel for castration-resistant prostate cancerKeisuke Shigeta, Yuji Miura, Yoichi Naito, et al.
Cancers|July 2, 2021
Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal TumorsToshirou Nishida, Shigetaka Yoshinaga, Tsuyoshi Takahashi, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2012
Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancerNobuaki Matsubara, Hirofumi Mukai, Yoichi Naito, et al.
International Journal of Clinical Oncology|February 28, 2025
Pimitespib in patients with advanced gastrointestinal stromal tumors in Japan: an expanded access programYoichi Naito, Shiro Iwagami, Toshihiko Doi, et al.
JCO Precision Oncology|August 8, 2024
Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case ReportMisao Fukuda, Toru Mukohara, Takeshi Kuwata, et al.
Gynecologic Oncology Reports|September 10, 2024
Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenanceTakehiro Nakao, Kenichi Harano, Masashi Wakabayashi, et al.
Future Oncology (London, England)|July 7, 2026
Plain language summary of the MiroCIP study: how often chemotherapy-induced peripheral neuropathy happens in the first year of oxaliplatin- or taxane-based chemotherapySonoko Misawa, Takahiro Kogawa, Yoichi Naito, et al.
Cancer Science|December 6, 2021
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumorsToshihiko Doi, Yasutoshi Kuboki, Yoichi Naito, et al.
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|August 12, 2011
Early prostate cancer--treat or watch?Keisuke Shigeta, Yoichi Naito, Toshimi Takano
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 13, 2023
Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumoursYoichi Naito, Toshirou Nishida, Toshihiko Doi
Lancet (London, England)|January 11, 2011
Cabazitaxel for castration-resistant prostate cancerKeisuke Shigeta, Yuji Miura, Yoichi Naito, et al.
Cancers|July 2, 2021
Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal TumorsToshirou Nishida, Shigetaka Yoshinaga, Tsuyoshi Takahashi, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2012
Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancerNobuaki Matsubara, Hirofumi Mukai, Yoichi Naito, et al.
International Journal of Clinical Oncology|February 28, 2025
Pimitespib in patients with advanced gastrointestinal stromal tumors in Japan: an expanded access programYoichi Naito, Shiro Iwagami, Toshihiko Doi, et al.
JCO Precision Oncology|August 8, 2024
Efficacy of Trametinib in Neurofibromatosis Type 1-Associated Gastrointestinal Stromal Tumors: A Case ReportMisao Fukuda, Toru Mukohara, Takeshi Kuwata, et al.
Gynecologic Oncology Reports|September 10, 2024
Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenanceTakehiro Nakao, Kenichi Harano, Masashi Wakabayashi, et al.
Future Oncology (London, England)|July 7, 2026
Plain language summary of the MiroCIP study: how often chemotherapy-induced peripheral neuropathy happens in the first year of oxaliplatin- or taxane-based chemotherapySonoko Misawa, Takahiro Kogawa, Yoichi Naito, et al.
Cancer Science|December 6, 2021
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumorsToshihiko Doi, Yasutoshi Kuboki, Yoichi Naito, et al.
Pageof 16